Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2051
iShares Global Energy ETF
IXC
$2.56B
| $3.29M | ﹤0.01% |
57,683
+38,694
| +204% | +$2.16M |
2024 Q4
7 quarters
|
|
2052
LuxExperience B.V.
LUXE
$1.47B
| $3.28M | ﹤0.01% |
331,142
+48,545
| +17% | +$394K |
2026 Q1
2 quarters
|
|
2053
Lexeo Therapeutics
LXEO
$236M
| $3.28M | ﹤0.01% |
969,155
-407,067
| -30% | -$1.84M |
2025 Q4
3 quarters
|
|
2054
Banco Santander
SAN
$176B
| $3.27M | ﹤0.01% |
+236,682
| New | +$3.38M |
2026 Q3
0 quarters
|
|
2055
CALL
Cleveland-Cliffs
CLF
$7.22B
| $3.27M | ﹤0.01% |
297,000
-7,000
| -2% | -$79.4K |
2024 Q2
9 quarters
|
|
2056
FerroAtlántica
GSM
$561M
| $3.26M | ﹤0.01% |
820,589
-330,322
| -29% | -$1.29M |
2026 Q2
1 quarter
|
|
2057
CALL
Barrick Mining
B
$61.2B
| $3.25M | ﹤0.01% |
80,000
-14,600
| -15% | -$598K |
2024 Q2
9 quarters
|
|
2058
CALL
Medtronic
MDT
$132B
| $3.25M | ﹤0.01% |
37,700
-13,300
| -26% | -$1.17M |
2024 Q4
7 quarters
|
|
2059
Sasol
SSL
$9.17B
| $3.25M | ﹤0.01% |
+234,915
| New | +$2.84M |
2026 Q3
0 quarters
|
|
2060
Maze Therapeutics
MAZE
$1.88B
| $3.25M | ﹤0.01% |
119,397
-11,646
| -9% | -$323K |
2026 Q1
2 quarters
|
|
2061
Natural Gas Services Group
NGS
$383M
| $3.24M | ﹤0.01% |
100,138
-22,146
| -18% | -$812K |
2023 Q3
12 quarters
|
|
2062
Amtech Systems
ASYS
$211M
| $3.24M | ﹤0.01% |
193,169
-1,545
| -0.8% | -$24.6K |
2025 Q4
3 quarters
|
|
2063
Cytokinetics
CYTK
$7.82B
| $3.24M | ﹤0.01% |
49,130
-523,405
| -91% | -$39.9M |
2024 Q4
7 quarters
|
|
2064
Quanta Services
PWR
$90.7B
| $3.24M | ﹤0.01% |
+5,035
| New | +$3.25M |
2026 Q3
0 quarters
|
|
2065
Costamare Bulkers Holdings
CMDB
$466M
| $3.23M | ﹤0.01% |
147,932
+30,370
| +26% | +$618K |
2025 Q2
5 quarters
|
|
2066
PUT
Apollo Global Management
APO
$72.9B
| $3.23M | ﹤0.01% |
27,800
+3,800
| +16% | +$482K |
2024 Q4
7 quarters
|
|
2067
Immix Biopharma
IMMX
$657M
| $3.22M | ﹤0.01% |
309,539
+167,575
| +118% | +$1.9M |
2025 Q4
3 quarters
|
|
2068
PUT
Agnico Eagle Mines
AEM
$90.2B
| $3.21M | ﹤0.01% |
17,500
-600
| -3% | -$106K |
2025 Q1
6 quarters
|
|
2069
iShares Gold Trust
IAU
$57.5B
| $3.19M | ﹤0.01% |
+40,909
| New | +$3.28M |
2026 Q3
0 quarters
|
|
2070
CALL
Dow Inc
DOW
$23.9B
| $3.19M | ﹤0.01% |
115,800
-2,700
| -2% | -$80.4K |
2024 Q4
7 quarters
|
|
2071
Euronet Worldwide
EEFT
$2.61B
| $3.19M | ﹤0.01% |
+50,676
| New | +$3.69M |
2026 Q3
0 quarters
|
|
2072
PUT
Regeneron Pharmaceuticals
REGN
$98.8B
| $3.18M | ﹤0.01% |
4,200
| – | – |
2023 Q3
12 quarters
|
|
2073
PUT
ON Semiconductor
ON
$27.7B
| $3.18M | ﹤0.01% |
41,400
-13,500
| -25% | -$1.08M |
2023 Q3
12 quarters
|
|
2074
Playtika
PLTK
$1.01B
| $3.17M | ﹤0.01% |
1,479,837
-881,291
| -37% | -$2.61M |
2023 Q3
12 quarters
|
|
2075
TransAlta
TAC
$4.18B
| $3.16M | ﹤0.01% |
261,920
-15,336
| -6% | -$195K |
2025 Q1
6 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.